SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Drugs >

Elite Pharmaceuticals (ELTP)

ELTP RSS Feed
Add ELTP Price Alert      Hide Sticky   Hide Intro
Moderator: Drugdoctor, dr_lowenstein, lasers, NASDAQ2020, IB_, Chasing
Search This Board: 
Last Post: 12/18/2017 12:15:34 AM - Followers: 833 - Board type: Free - Posts Today: 1

Elite Pharmaceuticals, Inc. (ELTP)

 
About Elite Pharmaceuticals
 
Elite Pharmaceuticals is a specialty pharmaceutical company specializing in niche generics and committed to the development of abuse-deterrent opioids to help curb diversion, misuse and abuse.  Elite has a pipeline of opioid abuse-deterrent products under development utilizing the company’s proprietary pharmacological abuse-deterrent technology. 
 
Located in Northvale, New Jersey, Elite operates a 55,000 square foot campus under Current Good Manufacturing Practice (“cGMP”) and is a United States Drug Enforcement Agency (“DEA”) registered facility for research, development, manufacturing and packaging of pharmaceutical products.
 
More information including Elite’s proprietary Abuse Resistant Technology can be found at http://www.elitepharma.com
 


About Elite's Abuse Deterrent Technology

Elite's abuse deterrent products utilize the Company's proprietary pharmacological abuse deterrent technology. Elite's abuse deterrent technology is a multi-particulate capsule which contains an opioid agonist in addition to naltrexone, an opioid antagonist. Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. When this product is taken as intended, the naltrexone is designed to pass through the body unreleased while the opioid agonist releases over time providing therapeutic pain relief for which it is prescribed. If the multi-particulate beads are crushed, the opioid antagonist, naltrexone, is designed to release. The absorption of the naltrexone is intended to block the euphoria by preferentially binding to same receptors in the brain as the opioid agonist and thereby reducing the incentive for abuse or misuse by recreational drug abusers.
 
Elite continues to expands the intellectual property for the Company's opioid abuse deterrent technology. Elite now has four US patents, one European patent, and two Canadian patents issued in this area with additional patents pending in the U.S., Canada and Europe.
 
Products & Pipeline
 
Screen%20Shot%202017-05-28%20at%2011.53.29%20AM.png
 
Elite’s principle product is SequestOx, an immediate-release oxycodone with sequestered naltrexone abuse-deterrent opioid product for the management of moderate to severe acute pain. Additional products include bariatric, cardiovascular, antihistamine, skeletal muscle relaxants, antipsychotic, tricyclic antidepressant, along with a number of approved products pending manufacturing site transfer.
 
Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy's Laboratories and Valeant Pharmaceuticals International. Additional information regarding Elite’s wholly owned products, partnerships, and contract manufacturing can be found at  http://www.elitepharma.com/products
 
The list of pipeline products can be found at http://www.elitepharma.com/pipeline-generics
 
Leadership
 
Nasrat Hakim, Chairman, President & Chief Executive Officer
 
Nasrat Hakim joined Elite in August 2013 as Director, President and Chief Executive Officer. Mr. Hakim has more than 30 years of pharmaceutical and medical industry experience in Quality Assurance, Analytical Research and Development, Technical Services and Regulatory Compliance. He brings with him proven management experience, in-depth knowledge of manufacturing systems, development knowledge in immediate and extended release formulations and extensive regulatory experience of GMP and FDA regulations. Prior to his leading Elite, from 2004 to 2013, Mr. Hakim was employed by Actavis, Watson and Alpharma in various senior management positions. Most recently, Mr. Hakim served as International Vice President of Quality Assurance at Actavis, overseeing 25 sites with more than 3,000 employees under his leadership.  Mr. Hakim also served as Corporate Vice President of Technical Services, Quality and Regulatory Compliance for Actavis U.S., Global Vice President, Quality and Regulatory Compliance for Alpharma, as well as Executive Director of Quality Unit at TheraTech, overseeing manufacturing and research and development. In 2009, Mr. Hakim founded Mikah Pharma, LLC, a virtual, fully functional pharmaceutical company. 

Mr. Hakim’s career started in Medical Laboratory Technology from the Academy of Health and Sciences in the U.S. Army based in San Antonio, TX, followed by Graduate Certification in Regulatory Affairs (RAC) from California State University at Sacramento, Sacramento, CA; Bachelor in Chemistry/Bio-Chemistry and Masters of Science in Chemistry from California State University at Sacramento, Sacramento, CA; and a Masters in Law with Graduate Certification in U.S. Taxation from St. Thomas University, School of Law, Miami, FL.
 

Investor Relations and Corporate Inquiries

Dianne Will
Vice President of Investor Relations and Corporate Affairs
Telephone: 518-398-6222
Email: 
dianne@elitepharma.com

Corporate Headquarters
165 Ludlow Avenue
Northvale, New Jersey 07647
Phone: 201-750-2646
Fax: 201-750-2755


 

Miscellaneous Links:
 
Elite Pharmaceuticals News
http://ir.elitepharma.com/press_releases
 
SEC Filings
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001053369&owner=include

FDA website
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails

Clinical Trials.Gov
https://www.clinicaltrials.gov/
 
Yahoo Finance
https://finance.yahoo.com/quote/ELTP/?p=ELTP
 
Seeking Alpha
https://seekingalpha.com/symbol/ELTP
 

ELTP Daily Chart
    


SureTrader
Interactive Brokers Advertisement
ELTP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ELTP News: Current Report Filing (8-k) 11/09/2017 05:05:42 PM
ELTP News: Quarterly Report (10-q) 11/09/2017 04:53:40 PM
ELTP News: Confidential Treatment Order (ct Order) 10/11/2017 12:26:51 PM
ELTP News: Current Report Filing (8-k) 09/07/2017 04:32:57 PM
ELTP News: Current Report Filing (8-k) 08/09/2017 05:01:18 PM
PostSubject
#279326  Sticky Note The last close out letter from the FDA toofun 12/08/17 11:57:54 AM
#277171  Sticky Note Links for November 10th Conference Call transcript/replay Chasing 11/12/17 01:57:56 PM
#274770  Sticky Note memorable "calls" for elite pharma: dr_lowenstein 10/24/17 04:09:11 PM
#271038  Sticky Note Elite Pharma at Pain Week 2017 NASDAQ2020 09/17/17 04:03:01 PM
#234937  Sticky Note THIS IS WHAT YOU NEED TO KNOW BEFORE Couch 11/30/16 03:04:07 PM
#189564  Sticky Note $ELTP SequestOx and ADF Patents lasers 03/18/16 04:29:26 AM
#185967  Sticky Note The only topic here is ELTP. IH Dan (Retired) 02/23/16 09:32:46 PM
#279654   Now that's real news and sure enough the newguy11 12/18/17 12:15:34 AM
#279653   that was fake news dr_lowenstein 12/17/17 08:12:22 PM
#279652   Total nonsense. Jimmy Joe 12/17/17 08:10:10 PM
#279651   $ELTP once had potential, but that potential has Sixman 12/17/17 07:02:35 PM
#279650   Why should we bother? greenlife 12/17/17 05:53:11 PM
#279649   Tell me how Elite is "on the right IB_ 12/17/17 02:22:50 PM
#279648   More fake news MM's betting we go lower newguy11 12/17/17 11:36:53 AM
#279647   Looks like entry into Canada, results positive . newguy11 12/17/17 11:33:57 AM
#279646   The more they shop around this SequestOx sharkey1 12/17/17 10:44:53 AM
#279645   If it was 40 million to 50 million stockboy 12/17/17 08:03:36 AM
#279644   -0-0-0-0-0-0 Zero pathways to .10–0-0-0-0-0! Oh my! stockboy 12/17/17 08:02:37 AM
#279643   The MMs short an OTC stock to make stockboy 12/17/17 05:44:06 AM
#279642   As far as Elite is concerned, IT DOESN'T IB_ 12/16/17 05:38:24 PM
#279641   Anda’s don’t mean squat. Approvals count. a CRL stockboy 12/16/17 05:13:00 PM
#279640   yeah, maybe nasrat will resign, that would be dr_lowenstein 12/16/17 04:32:38 PM
#279639   Something has to give here soon. Agree Elite Jimmy Joe 12/16/17 04:00:52 PM
#279638   I know failure after failure is not an stockboy 12/16/17 02:45:37 PM
#279635   Completely agree. AJSails 12/16/17 02:23:03 PM
#279634   I don't know if it means anything, but sharkey1 12/16/17 10:56:55 AM
#279633   Leave a few for me Yogi. NASDAQ2020 12/15/17 09:16:53 PM
#279632   How about 21 pathways to .10? ROFLMAO FAKE NEWS! stockboy 12/15/17 04:43:09 PM
#279631   4 Filings will be another year plus more stockboy 12/15/17 04:40:03 PM
#279629   ELTP ????????????????????????????????????? IB_ 12/15/17 04:13:34 PM
#279628   I want Santa to bring me some ELTP. NASDAQ2020 12/15/17 03:38:37 PM
#279627   Stock, I have averaged down recently myself several times infact! snupoled 12/15/17 03:16:05 PM
#279626   I just keep adding ELTP!!! She’s going to stock_mom 12/15/17 03:03:38 PM
#279625   Got a few at .0865 today newguy11 12/15/17 02:13:17 PM
#279624   Waiting to add more mid next week don’t rocioyogi 12/15/17 02:04:47 PM
#279623   Glad to be averaging up at these prices. NASDAQ2020 12/15/17 01:23:58 PM
#279622   $$$$ 20 Pathways to DollarLand $$$$ NASDAQ2020 12/15/17 01:12:08 PM
#279621   "All these five resulted in [two item 483] IB_ 12/15/17 12:33:45 PM
#279620   All these five resulted in [two item 483] sharkey1 12/15/17 11:37:43 AM
#279619   Elites " pade getting resolved at the same IB_ 12/15/17 11:27:30 AM
#279618   From 2 cc's ago, last Aug. sharkey1 12/15/17 11:12:01 AM
#279617   Doctor WeeZuhl Does $ELTP need FDA official lasers 12/15/17 10:57:31 AM
#279616   I hope we go lower today so I newguy11 12/15/17 10:43:15 AM
#279613  Restored littleHody, All loyal longs try in our own ways snupoled 12/15/17 10:07:34 AM
#279611   Snup, Will you apply for the ELTP Investor Relations littlerhody 12/15/17 09:46:00 AM
#279609   I see it as Nasrat is like a IB_ 12/15/17 09:41:06 AM
#279608   Actually its better to buy low sell high newguy11 12/15/17 09:40:05 AM
#279607   IB holding too I have the HOPE strategy stockboy 12/15/17 09:24:31 AM
#279606   I'm holding Elite at this price with the IB_ 12/15/17 09:06:47 AM
#279605   IB, you are correct for today anyways, snupoled 12/15/17 08:52:36 AM
#279604   stock, that may very well be what happens to snupoled 12/15/17 08:47:41 AM
#279603   I thought you meant the FDA was the stockboy 12/15/17 08:38:09 AM
#279602   I'm joking because there is no Santa, I think. toofun 12/15/17 08:16:18 AM
#279601   It’s always good for losers to average down. stockboy 12/15/17 07:53:53 AM
#279600   Great timing. NASDAQ2020 12/15/17 07:36:21 AM
#279599   I too have seen the -75% drop stockboy 12/15/17 04:31:07 AM
#279598   But we all know it's the MLK trading stockboy 12/15/17 04:30:16 AM
PostSubject